ADV Pharma: what changed
ADV Pharma
Largest movements
- Tangible fixed assets +€1.7m
up €1.7m (+227%), from €769,091 to €2.5m
of which Assets under construction and advance payments: +€1.3m
- Cash -€244,661
down €244,661 (-65.9%), from €371,012 to €126,351
mainly Investment in fixed assets (net) (-€1.8m) and Contributions, distributions and other (-€740,000)
- Receivables within one year -€77,909
down €77,909 (-6.2%), from €1.3m to €1.2m
of which Other amounts receivable: -€71,143
- Debts after one year +€842,634
up €842,634 (+78.5%), from €1.1m to €1.9m
of which Financial debts: +€845,683
- Other debts +€454,024
up €454,024 (+30.3%), from €1.5m to €2.0m
- Trade debts +€377,897
up €377,897 (+525%), from €71,926 to €449,823
- Reserves -€240,000
down €240,000 (-12.3%), from €1.9m to €1.7m
of which Distributable reserves: -€240,000
- Tax, wage and social debts -€85,926
down €85,926 (-55.3%), from €155,271 to €69,345
- Financial income -€105,899
down €105,899 (-26.0%), from €406,662 to €300,764
- Taxes -€75,881
down €75,881 (-71.7%), from €105,881 to €30,000
- Gross operating margin -€71,866
down €71,866 (-14.4%), from €498,021 to €426,155
- Write-downs +€68,566
new in 2025: €68,566
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,769,369 | €7,250,810 | +€1.5m | +25.7% |
| Fixed assets | 21/28 | €3,513,661 | €5,262,222 | +€1.7m | +49.8% |
| Tangible fixed assets | 22/27 | €769,091 | €2,517,652 | +€1.7m | +227% |
| Land and buildings | 22 | €715,028 | €1,177,418 | +€462,390 | +64.7% |
| Plant, machinery and equipment | 23 | €760 | €311 | -€449 | -59.1% |
| Furniture and vehicles | 24 | €834 | €244 | -€590 | -70.8% |
| Assets under construction and advance payments | 27 | €52,469 | €1,339,679 | +€1.3m | +2,453% |
| Financial fixed assets | 28 | €2,744,570 | €2,744,570 | = | 0.0% |
| Current assets | 29/58 | €2,255,708 | €1,988,588 | -€267,120 | -11.8% |
| Amounts receivable within one year | 40/41 | €1,265,019 | €1,187,110 | -€77,909 | -6.2% |
| Trade receivables | 40 | €6,767 | - | -€6,767 | |
| Other amounts receivable | 41 | €1,258,252 | €1,187,110 | -€71,143 | -5.7% |
| Cash at bank and in hand | 54/58 | €371,012 | €126,351 | -€244,661 | -65.9% |
| Deferred charges and accrued income | 490/1 | €619,677 | €675,127 | +€55,451 | +8.9% |
| Total equity and liabilities | 10/49 | €5,769,369 | €7,250,810 | +€1.5m | +25.7% |
| Equity | 10/15 | €2,690,920 | €2,507,332 | -€183,588 | -6.8% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €1,947,312 | €1,707,312 | -€240,000 | -12.3% |
| Non-distributable reserves | 130/1 | €10,000 | €10,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €10,000 | €10,000 | = | 0.0% |
| Distributable reserves | 133 | €1,937,312 | €1,697,312 | -€240,000 | -12.4% |
| Profit (loss) carried forward | 14 | €643,608 | €700,020 | +€56,412 | +8.8% |
| Amounts payable | 17/49 | €3,078,449 | €4,743,478 | +€1.7m | +54.1% |
| Amounts payable after more than one year | 17 | €1,073,148 | €1,915,782 | +€842,634 | +78.5% |
| Financial debts | 170/4 | €998,467 | €1,844,150 | +€845,683 | +84.7% |
| Other amounts payable | 178/9 | €74,681 | €71,632 | -€3,049 | -4.1% |
| Amounts payable within one year | 42/48 | €2,005,300 | €2,827,696 | +€822,396 | +41.0% |
| Current portion of amounts payable after more than one year | 42 | €280,618 | €282,019 | +€1,401 | +0.5% |
| Financial debts | 43 | - | €75,000 | +€75,000 | |
| Credit institutions | 430/8 | - | €75,000 | +€75,000 | |
| Trade debts | 44 | €71,926 | €449,823 | +€377,897 | +525% |
| Suppliers | 440/4 | €71,926 | €449,823 | +€377,897 | +525% |
| Taxes, remuneration and social security | 45 | €155,271 | €69,345 | -€85,926 | -55.3% |
| Taxes | 450/3 | €155,271 | €69,345 | -€85,926 | -55.3% |
| Other amounts payable | 47/48 | €1,497,485 | €1,951,509 | +€454,024 | +30.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €26,203 | €26,149 | -€54 | -0.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €68,566 | +€68,566 | |
| Other operating charges | 640/8 | €0 | - | -€0 | |
| Gross operating margin | 9900 | €498,021 | €426,155 | -€71,866 | -14.4% |
| Operating profit (loss) | 9901 | €471,818 | €331,441 | -€140,377 | -29.8% |
| Financial income | 75/76B | €406,662 | €300,764 | -€105,899 | -26.0% |
| Recurring financial income | 75 | €406,662 | €300,764 | -€105,899 | -26.0% |
| Financial charges | 65/66B | €42,908 | €45,792 | +€2,884 | +6.7% |
| Recurring financial charges | 65 | €42,908 | €45,792 | +€2,884 | +6.7% |
| Profit (loss) for the period before taxes | 9903 | €835,572 | €586,412 | -€249,160 | -29.8% |
| Income taxes | 67/77 | €105,881 | €30,000 | -€75,881 | -71.7% |
| Profit (loss) for the period | 9904 | €729,691 | €556,412 | -€173,278 | -23.7% |
| Profit (loss) for the period to be appropriated | 9905 | €729,691 | €556,412 | -€173,278 | -23.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.